HealthEquity, Inc. (HQY)
NASDAQ: HQY · Real-Time Price · USD
108.60
-3.12 (-2.79%)
Feb 21, 2025, 4:00 PM EST - Market closed
HealthEquity Market Cap
HealthEquity has a market cap or net worth of $9.41 billion as of February 21, 2025. Its market cap has increased by 42.57% in one year.
Market Cap
9.41B
Enterprise Value
10.22B
1-Year Change
42.57%
Ranking
Category
Stock Price
$108.60
Market Cap Chart
Since July 31, 2014, HealthEquity's market cap has increased from $872.90M to $9.41B, an increase of 978.20%. That is a compound annual growth rate of 25.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2025 | 9.68B | 16.44% |
| Dec 31, 2024 | 8.32B | 46.17% |
| Dec 29, 2023 | 5.69B | 9.04% |
| Dec 30, 2022 | 5.22B | 41.06% |
| Dec 31, 2021 | 3.70B | -31.09% |
| Dec 31, 2020 | 5.37B | 2.23% |
| Dec 31, 2019 | 5.25B | 41.07% |
| Dec 31, 2018 | 3.72B | 31.46% |
| Dec 29, 2017 | 2.83B | 17.68% |
| Dec 30, 2016 | 2.41B | 66.51% |
| Dec 31, 2015 | 1.44B | 3.67% |
| Dec 31, 2014 | 1.39B | 59.64% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |